Paul Calvo

Paul A. Calvo, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. 

Paul advises a diverse group of biotechnology and pharmaceutical companies, with a particular focus on counseling European life sciences clients as they navigate US intellectual property concerns.  

He works closely with innovators on global patent portfolio strategy, licensing, patent validity, infringement, and design-around strategies. 

Paul specializes in technologies that include large molecule therapies, such as therapeutic antibodies, chimeric antigen receptors, and polypeptide therapeutics, antibody drug conjugates, and genomics applications as well as medical devices.